S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The "King Of Quants" sees 10X potential... (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The "King Of Quants" sees 10X potential... (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The "King Of Quants" sees 10X potential... (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Urgent Warning (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
The "King Of Quants" sees 10X potential... (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
BREAKING: Tiny biotech successfully treats blindness (Ad)
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment

Clorox - CLX Earnings Date, Estimates & Call Transcripts

$157.76
+0.26 (+0.17%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$157.50
$159.00
50-Day Range
$139.79
$157.76
52-Week Range
$120.50
$160.59
Volume
845,851 shs
Average Volume
1.21 million shs
Market Capitalization
$19.49 billion
P/E Ratio
45.07
Dividend Yield
2.99%
Price Target
$141.00

Earnings Summary

Upcoming
Earnings Date
May. 1Estimated
Actual EPS
(Feb. 2)
$0.98 Beat By $0.32
Consensus EPS
(Feb. 2)
$0.66
Last Year's Q1 EPS
(2/3/2022)
$0.66
Skip Charts & View Estimated and Actual Earnings Data

CLX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Clorox Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20232$0.53$0.78$0.66 
Q2 20232$0.69$0.70$0.70 
Q3 20232$1.02$1.39$1.21 
Q4 20231$0.99$0.99$0.99 
FY 20237$3.23$3.86 $3.55

CLX Earnings Date and Information

Clorox last released its earnings data on February 2nd, 2023. The reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.66 by $0.32. The firm earned $1.72 billion during the quarter, compared to analyst estimates of $1.66 billion. Its quarterly revenue was up 1.4% on a year-over-year basis. Clorox has generated $3.50 earnings per share over the last year ($3.50 diluted earnings per share) and currently has a price-to-earnings ratio of 45.1. Earnings for Clorox are expected to grow by 27.19% in the coming year, from $4.23 to $5.38 per share. Clorox has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 1st, 2023 based off prior year's report dates.

Clorox Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/1/2023
(Estimated)
        
2/2/2023Q2 23$0.66$0.98+$0.32$1.16$1.66 billion$1.72 billion      
11/1/2022Q1 2023$0.73$0.93+$0.20$1.18$1.69 billion$1.74 billion
8/3/2022Q4 2022$0.95$0.93($0.02)$1.05$1.86 billion$1.80 billion
5/2/2022Q3 2022$0.97$1.31+$0.34$1.41$1.81 billion$1.81 billion      
2/3/2022Q2 2022$0.78$0.66($0.12)$0.76$1.68 billion$1.69 billion    
10/31/20219/30/2021$1.03$1.21+$0.18$1.28$1.70 billion$1.81 billion    
8/3/20216/30/2021$1.29$0.95($0.34)$1.12$1.91 billion$1.80 billion    
4/29/20213/31/2021$1.48$1.62+$0.14$3.73$1.86 billion$1.78 billion  
2/3/202112/31/2020$1.78$2.03+$0.25$2.03$1.75 billion$1.84 billion  
11/7/20209/30/2020$2.32$3.22+$0.90$3.22$1.74 billion$1.92 billion    
8/3/20206/30/2020$2.00$2.41+$0.41$2.41$1.86 billion$1.98 billion  
5/1/20203/31/2020$1.72$1.89+$0.17$1.89$1.69 billion$1.78 billion  
2/4/2020Q2 2020$1.31$1.46+$0.15$1.46$1.45 billion$1.45 billion  
10/31/2019Q1 2020$1.54$1.59+$0.05$1.59$1.51 billion$1.51 billion    
8/1/2019Q4 2019$1.84$1.88+$0.04$1.88$1.69 billion$1.63 billion  
5/1/20193/31/2019$1.47$1.44($0.03)$1.44$1.57 billion$1.55 billion    
2/4/201912/31/2018$1.32$1.40+$0.08$1.40$1.47 billion$1.47 billion  
10/31/20189/30/2018$1.59$1.62+$0.03$1.62$1.53 billion$1.56 billion  
8/2/2018Q4 2018$1.58$1.66+$0.08$1.66$1.72 billion$1.69 billion
5/2/2018Q3 2018$1.31$1.37+$0.06$1.37$1.51 billion$1.52 billion
2/2/2018Q2 2018$1.22$1.23+$0.01$0.69$1.43 billion$1.42 billion    
11/1/2017Q1 2018$1.41$1.46+$0.05$1.46$1.48 billion$1.50 billion
8/3/2017Q4 2017$1.49$1.53+$0.04$1.54$1.65 billion$1.65 billion  
5/3/2017Q3 2017$1.2970$1.3090+$0.0120$1.31$1.48 billion$1.48 billion  
2/3/2017Q217$1.22$1.25+$0.03$1.36$1.41 billion$1.41 billion
11/2/2016Q117$1.42$1.36($0.06)$1.36$1.24 billion$1.44 billion
8/3/2016Q416$1.28$1.26($0.02)$1.26$1.58 billion$1.60 billion  
5/3/2016Q316$1.11$1.21+$0.10$1.19$1.41 billion$1.43 billion
2/4/2016Q216$1.05$1.14+$0.09$1.15$1.35 billion$1.35 billion  
11/2/2015Q116$1.18$1.32+$0.14$1.33$1.37 billion$1.39 billion  
8/3/2015Q415$1.37$1.44+$0.07$1.42$1.52 billion$1.56 billion
5/1/2015Q315$1.10$1.08($0.02)$0.86$1.38 billion$1.40 billion  
2/4/2015Q215$0.90$0.97+$0.07$0.99$1.30 billion$1.35 billion  
10/31/2014Q115$1.03$1.10+$0.07$1.52$1.33 billion$1.35 billion  
8/1/2014Q4$1.34$1.40+$0.06$1.51$1.52 billion$1.51 billion  
5/1/2014Q314$1.08$1.18+$0.10$1.32$1.43 billion$1.39 billion  
2/4/2014Q2 2014$0.91$0.88($0.03)$0.89$1.31 billion$1.33 billion  
10/31/2013Q1 2014$1.00$1.04+$0.04$1.05$1.35 billion$1.36 billion  
8/1/2013Q4 2013$1.34$1.38+$0.04$1.39$1.57 billion$1.55 billion
5/1/2013Q3 2013$1.06$1.00($0.06)$1.00$1.44 billion$1.41 billion  
2/4/2013Q2 2013$0.80$0.90+$0.10$1.27 billion$1.33 billion  
10/31/2012Q113$0.95$1.01+$0.06$1.35 billion$1.34 billion  
8/2/2012$1.27$1.32+$0.05
5/2/2012$1.04$1.02($0.02)  
2/3/2012$0.69$0.79+$0.10
11/2/2011$0.93$1.04+$0.11  
8/3/2011$1.20$1.26+$0.06
5/3/2011$1.04$1.02($0.02)
2/4/2011$0.61$0.68+$0.07
11/2/2010Q1 2011$1.13$1.08($0.05)$0.64
8/3/2010Q4 2010$1.20$1.22+$0.02$1.24
5/3/2010Q3 2010$1.09$1.16+$0.07$1.16
2/4/2010Q2 2010$0.75$0.77+$0.02$0.77
11/2/2009Q1 2010$0.95$1.14+$0.19$1.17
8/3/2009Q4 2009$1.20$1.25+$0.05$1.30
5/1/2009Q3 2009$0.90$1.08+$0.18$1.08
2/4/2009Q2 2009$0.58$0.62+$0.04$0.62
10/31/2008Q1 2009$0.84$0.95+$0.11$0.99
8/1/2008Q4 2008$1.11$1.18+$0.07$1.23
5/1/2008Q3 2008$0.77$0.84+$0.07$0.97
2/4/2008Q2 2008$0.56$0.69+$0.13$0.73












Clorox Earnings - Frequently Asked Questions

When is Clorox's earnings date?

Clorox has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 1st, 2023 based off last year's report dates. Learn more on CLX's earnings history.

Did Clorox beat their earnings estimates last quarter?

In the previous quarter, Clorox (NYSE:CLX) reported $0.98 earnings per share (EPS) to beat the analysts' consensus estimate of $0.66 by $0.32. Learn more on analysts' earnings estimate vs. CLX's actual earnings.

How can I listen to Clorox's earnings conference call?

The conference call for Clorox's latest earnings report can be listened to online. Listen to Conference Call

How can I read Clorox's conference call transcript?

The conference call transcript for Clorox's latest earnings report can be read online. Read Transcript

How can I view Clorox's earnings report?

Clorox's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does Clorox generate each year?

Clorox (NYSE:CLX) has a recorded annual revenue of $7.11 billion.

How much profit does Clorox generate each year?

Clorox (NYSE:CLX) has a recorded net income of $462 million. CLX has generated $3.50 earnings per share over the last four quarters.

What is Clorox's price-to-earnings ratio?

Clorox (NYSE:CLX) has a trailing price-to-earnings ratio of 45.07 and a forward price-to-earnings ratio of 37.30. The price/earnings-to-growth ratio is 3.18.

What is Clorox's EPS forecast for next year?

Clorox's earnings are expected to grow from $4.23 per share to $5.38 per share in the next year, which is a 27.19% increase.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NYSE:CLX) was last updated on 3/28/2023 by MarketBeat.com Staff